Search results
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 - Ocular...
Benzinga· 1 day agoOCUL "Ocular", the "Company"))), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization of innovative therapies ...
...-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming...
WKRN Nashville· 2 days agoEB-105 is a novel trispecific fusion antibody targeting VEGF-A (and isomers), VEGF-B, placental growth factor (PlGF), angiopoetin-2 (Ang-2), and interleukin-6 receptor (IL-6R) for the
Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema
Digital Journal· 2 days agoHeadquartered in Menlo Park, California, Emmecell is also the parent company...
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 6 days agoNonetheless, Vabysmo, approved for wet macular degeneration in 2022, reported a tripling of drug...
Seven Things Everyone Should Know About Retina Specialists
Newswise· 2 days agoMillions of Americans have retina specialists to thank for saving their vision from conditions such as age-related macular degeneration (AMD) and diabetic ...
Cognition Therapeutics hits enrollment goal in DLB study By Investing.com
Investing.com· 3 days agoCognition Therapeutics, Inc. (NASDAQ: CGTX), a biopharmaceutical company focused on...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoWhile development potential and interest for this novel treatment approach is high for more rare inherited conditions such as retinitis pigmentosa and Stargardt's, Spherix's ...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks· 16 hours agoRegeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Zacks· 3 days agoA significant chunk of Regeneron’s revenues come from the sales of its lead drug, Eylea, which is approved for various ophthalmology indications (neovascular age-related macular< ...
Can You Take Vitamin C and Iron Together?
Health via Yahoo News· 2 days agoIron is often sold in products that also contain vitamin C. Vitamin C can enhance iron absorption, but, as with all supplements, there are...